"COVID-19 Update: We're pleased to announce that Cosmedica is now open! We have implemented new protocols to ensure the safety of our patients and staff – contact us to learn more or to request an appointment. We are continuing to fulfill product orders via contactless pickup. Call or email us to place your order and arrange for pickup. We look forward to seeing you!"

During the past decade, Cosmedica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cosmedica" are "Axillary Hyperhidrosis" (1 trials) and "Erythematotelangiectatic Rosacea" (1 trials). Many other conditions were trialed in "Cosmedica" in a lesser frequency.

Most popular intervention types in "Cosmedica" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ulthera System providing one treatment per cheek" (1 trials), "Ulthera System providing two treatments per cheek" (1 trials) and "miraDry System (treatment with energy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cosmedica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cosmedica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cosmedica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cosmedica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".